Cassona Global Imaging, a leading provider of diagnostic imaging solutions, has provided free hands-on training to 67 ...

Thanks to rising healthcare expenditure and a greater demand for accessible solutions. India’s diagnostic imaging market is ...

Gurugram-based Modern Diagnostic, a pathology and imaging firm, filed its initial draft papers with the markets regulator ...

PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...

India’s diagnostic imaging market is poised for substantial growth, and is set to exceed $7 billion in 2033, according to a ...

Proving causation is a challenge in healthcare, legal cases, and scientific research. How can professionals confirm that an ...

Swedish researchers have identified genetic variants that increase the risk of atherosclerosis. The aim is for these new ...

As of 2024, India accounts for approximately 20 per cent of the Asia-Pacific (APAC) diagnostic imaging devices market. The ...

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...

Swedish researchers have identified genetic variants that increase the risk of atherosclerosis. The aim is for these new ...